The Recall Desk
SevereFDA (Drugs)·D-1037-2016·Announced 2016-06-22

Fresenius Kabi Recalls Sensorcaine Due to Glass Particulate Matter

Fresenius Kabi is recalling specific lots of Sensorcaine injection because glass particulate matter was found in the sterile product.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for significant injury or property damage reports or high-risk contamination.

Plain-English summary

Fresenius Kabi USA, LLC is recalling 69,225 units of Sensorcaine (Bupivacaine Hydrochloride and Epinephrine Bitartrate) 0.75% in 30 mL single-dose vials. The recall was initiated because glass particulate matter was found in the sterile injectable product.

The affected product is identified by Lot # 6111504 with an expiration date of 09/2019. The product is distributed nationwide. Sensorcaine is a prescription drug used for infiltration and perineural routes.

Healthcare providers and patients should stop using the affected lots and contact Fresenius Kabi USA, LLC for further instructions or replacement.

The recalled product

Product
SENSORCAINE (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE)
Brand
SENSORCAINE
Affected units
69,225

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: 6111504
  • Exp 09/2019

UPCs (6)

  • 0363323472030
  • 0363323461010
  • 0363323463014
  • 0363323468026
  • 0363323472016
  • 0363323468019

Distribution

Distributed nationwide across the United States.

Same manufacturer · Fresenius Kabi USA, LLC

See all →